SLP · Nasdaq · Healthcare · Health Information Services
$18.500.0%Oct 5 close
Figures through May 31, 2026, from the 10-Q filed July 9, 2026
The quarter ending May 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toMay 31, 2026 | 3 months toMay 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $21.9M | $20.4M | +7.48% |
| Profit | $3.6M | -$67.3M | +105.31% |
| Profit per share | $0.18 | -$3.35 | +105.37% |
| Free Cash Flow | $8.6M | $7.8M | +9.80% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“We delivered solid third quarter results, with revenue increasing 7%, highlighted by strength in our services revenue, which grew 20%, while software revenue was flat year over year,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Simulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through innovative science-based software and consulting solutions.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Simulations Plus, Inc.’s Item 2.02 8-K filed July 9, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Simulations Plus, Inc. has no earnings call transcript available.